Springbok Capital Management »

Catalyst Pharmaceutical Partners shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $413k 26k 15.94
2023-09-30 $164k 14k 11.69
2019-06-30 $89k 23k 3.82
2017-09-30 $999 270 3.70
2017-06-30 $2.0k 810 2.47

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Brighthouse Finl (BHF)
Bio Rad Labs Cl A (BIO)
Baidu Spon Adr Rep A (BIDU)
Pioneer Natural Resources (PXD)
Hess (HES)
Microsoft Corporation (MSFT)
Overstock (BYON)
Netease Sponsored Ads (NTES)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Springbok Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners